Navigation Links
Cardium Presents First Quarter 2012 Financial Results and Recent Developments
Date:5/15/2012

, 2012Three Months Ended March 31,20122011Revenues$
20,478$
--Cost of goods sold5,455--Gross profit15,023--Research and development(1,164,599)(491,574)Selling, general and administrative(1,509,761)(1,287,885)Loss from operations(2,659,337)(1,779,459)Interest income (expense), net1,1442,649Change in fair value of derivative liabilities64,15788,170Net loss $  (2,594,036)$ (1,688,640) 

Net  loss per common  share – basic and diluted $
(0.02) $
(0.02)Weighted average common shares outstanding  – basic and diluted 

109,279,152 

83,097,967Selected Condensed Consolidated Balance Sheet DataMarch 31,

2012December 31,

2011Cash and cash equivalents

$
9,070,522$
4,721,279Restricted cash

50,000200,000Accounts receivable

17,546--Inventory

521,657434,130Prepaid expenses and other current assets

111,26668,204Property and equipment, net

111,701135,581Other long-term assets

1,910,4331,944,035Total assets

$   11,793,125$
7,503,229Accounts payable and accrued liabilities

$
,690,399$
,214,480Derivative liabilities

--85,506Long-term liabilities

105,353118,313Total liabilities

1,795,7521,418,299Stockholder's equity

9,997,3736,084,930Total liabilities and stockholder's equity

$   11,793,125$
7,503,299Cardium Therapeutics, Inc.Reconciliation of Non-GAAP MeasureAs of March 31, 2012Three Months Ended March 31,20122011Net Loss 

$ (2,594,036)


$ (1,688,640)Add (subtract)Stock-based compensation expense43,23933,915Change in fair value of derivative liabilities(64,157)(88,170)Non-GAAP net loss$ (2,614,954)$ (1,742,895)Non-GAAP net loss per common share – basic
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Cardium to Present at Upcoming Investor Conferences
2. Cardiums Exchange Listing Compliance Plan Accepted by NYSE Amex
3. Cardium Reports Excellagen Matrix Clinical Study Results Accepted for Publication by Peer-Reviewed Journal, and Updates Product Plans
4. Cardium Reports on Third Quarter 2010 Financial Results and Recent Developments
5. Cardium to Present at the LifeTech Capital Miami Medical Investors Conference
6. Cardium Gains Exclusive Access to Novel Polymer-Based Nitric Oxide Technology for Expansion of Wound Healing Product Portfolio
7. Cardium to Present at 10th Annual Biotech in Europe Investor Forum
8. Cardium Regains Listing Compliance With NYSE Amex
9. Cardium to Present at MDB Capital Groups 2010 Bright Lights Conference
10. Cardiums Exchange Listing Compliance Plan Accepted by NYSE AMEX
11. Cardium Reports on Third Quarter 2009 Financial Results and Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... San Francisco, CA (PRWEB) February 27, 2015 ... is joining forces on February 28 with patients and ... to raise awareness for Rare Disease Day®. Rare ... rare diseases and calling attention to the special challenges ... community around them. , “Cytokinetics is proud to stand ...
(Date:2/26/2015)... Calif. , Feb. 26, 2015  23andMe, the ... Kate Black as Privacy Officer and Corporate ... and state privacy laws as well as health care ... team, she will be responsible for reviewing, updating and ... in the U.S. and abroad. She joined the company ...
(Date:2/26/2015)... , Feb. 26, 2015 DuPont Executive ... priorities driven by key research advancements and product launches ... today,s Bank of America Merrill Lynch 2015 Global Agriculture ... challenge of building grain supplies the last two years, ... at the pace of the last decade, when demand ...
(Date:2/26/2015)... 2015 BioEnterprise today announced that ... than $2 billion in growth funding during the past ... strategic sources, state – including the Ohio Third Frontier ... billion has been raised in the past five years. ... of the BioEnterprise Midwest Healthcare Growth Capital  Report. ...
Breaking Biology Technology:Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 623andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 4DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 5More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 2More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 4
... November 14, 2011 BSP Biological ... and manufactures products for the non-invasive, accurate diagnosis of ... of a comprehensive clinical research study evaluating the performance ... article describing the study and its results was accepted ...
... Incorporated (NASDAQ: SPEX ) -- an innovator ... atherosclerosis, and providers of technical and regulatory consulting services ... reported financial results for the three and nine months ... Upcoming Highlights Pharmaceutical Development ...
... 2011 Synteract, Inc., a full-service, global contract research ... company focused on novel, small-molecule therapeutics for the treatment ... American Lung Association (ALA) in California in their annual ... team participation and donations. The two companies also are ...
Cached Biology Technology:Positive Clinical Study Results for BSP's HyperQ Technology 2Positive Clinical Study Results for BSP's HyperQ Technology 3Spherix Announces Third Quarter Financial Results 2Spherix Announces Third Quarter Financial Results 3Spherix Announces Third Quarter Financial Results 4Spherix Announces Third Quarter Financial Results 5Spherix Announces Third Quarter Financial Results 6Spherix Announces Third Quarter Financial Results 7Synteract and MediciNova Partner in "Fight For Air Walk" to Support the American Lung Association in California 2Synteract and MediciNova Partner in "Fight For Air Walk" to Support the American Lung Association in California 3
(Date:2/11/2015)... February 11, 2015 ... "Access Control Market by Product (Cards and Readers, Biometrics, ... Defense, Government, Industrial, Healthcare, Education) and By Geography - Global ... MarketsandMarkets, the Access Control Market is expected ... at a CAGR of 10.6% between 2014 ...
(Date:2/9/2015)... Feb. 9, 2015  Lintec of America recently announced ... carbon nanotube (CNT) macrostructures, including sheets, yarns and ribbons, ... Leveraging the vast industrial resources of the ... , Lintec of America is forming the Nano-Science ... , focusing on scaling up the manufacturing and ...
(Date:2/5/2015)... , Feb. 5, 2015  Marken is starting its ... and has launched a new marketing campaign to solidify ... (CLO).  The new campaign focuses on First ... and shipments. The first headline in the ... Marken,s priorities with its client,s priorities. Marken recognizes the ...
Breaking Biology News(10 mins):Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marken Launches New Patient-Centric Campaign 2
... (SACRAMENTO, Calif.) Surgeons from UC Davis Medical ... ability of patients with facial paralysis to blink, a ... year who no longer are able to close their ... facial surgery. In addition, the technique, which uses ...
... the SIB Swiss Institute of Bioinformatics led an analysis ... to the public, the parasitic wasps kill pest insects. ... kill only specific kinds of insects. Harnessing their full ... which broadly kill or poison many organisms in the ...
... ESHRE invites you to attend its workshop on ... a hands on course on ,Derivation and culture of pluripotent ... is to provide participants with an update on the state ... the hands on workshop during the following days 9-12 February ...
Cached Biology News:Artificial muscles restore ability to blink, save eyesight 2Artificial muscles restore ability to blink, save eyesight 3Parasitic wasps' newly sequenced genomes reveal new avenues for pest control 2Update on pluripotent stem cells (hESC and iPS) 2